CN116035991A - Plant extract composition with antiallergic and soothing effects and cosmetic - Google Patents
Plant extract composition with antiallergic and soothing effects and cosmetic Download PDFInfo
- Publication number
- CN116035991A CN116035991A CN202310053921.3A CN202310053921A CN116035991A CN 116035991 A CN116035991 A CN 116035991A CN 202310053921 A CN202310053921 A CN 202310053921A CN 116035991 A CN116035991 A CN 116035991A
- Authority
- CN
- China
- Prior art keywords
- extract
- cosmetic
- soothing
- cogongrass rhizome
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 230000000694 effects Effects 0.000 title claims abstract description 31
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 15
- 239000000419 plant extract Substances 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 81
- 241001598107 Imperata Species 0.000 claims abstract description 71
- 229940064064 purslane extract Drugs 0.000 claims abstract description 10
- 206010070834 Sensitisation Diseases 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 19
- 244000025254 Cannabis sativa Species 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 229960001631 carbomer Drugs 0.000 claims description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 4
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 4
- 229940043234 carbomer-940 Drugs 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000003906 humectant Substances 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- 229940085237 carbomer-980 Drugs 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- -1 pH regulator Substances 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 22
- 210000003630 histaminocyte Anatomy 0.000 abstract description 12
- 210000002615 epidermis Anatomy 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 8
- 210000004027 cell Anatomy 0.000 abstract description 8
- 230000004054 inflammatory process Effects 0.000 abstract description 8
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 244000248557 Ophiopogon japonicus Species 0.000 abstract description 7
- 206010040880 Skin irritation Diseases 0.000 abstract description 7
- 230000036556 skin irritation Effects 0.000 abstract description 7
- 231100000475 skin irritation Toxicity 0.000 abstract description 7
- 201000004624 Dermatitis Diseases 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 206010040844 Skin exfoliation Diseases 0.000 abstract description 5
- 230000002159 abnormal effect Effects 0.000 abstract description 5
- 230000035618 desquamation Effects 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 238000006748 scratching Methods 0.000 abstract description 4
- 230000002393 scratching effect Effects 0.000 abstract description 4
- 229930195210 Ophiopogon Natural products 0.000 abstract description 3
- 230000008719 thickening Effects 0.000 abstract description 3
- 230000008313 sensitization Effects 0.000 abstract description 2
- 241000699670 Mus sp. Species 0.000 description 36
- 230000000052 comparative effect Effects 0.000 description 21
- 238000009472 formulation Methods 0.000 description 10
- 108010003272 Hyaluronate lyase Proteins 0.000 description 9
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 9
- 229960002773 hyaluronidase Drugs 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010000349 Acanthosis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000732800 Cymbidium Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a plant extract composition with anti-allergy and soothing effects and a cosmetic, wherein the plant extract composition comprises a cogongrass rhizome extract, a dwarf lilyturf tuber extract and a purslane extract. Animal experiments show that the cogongrass rhizome extract as an active ingredient can reduce the skin inflammation desquamation condition, reduce scratching condition, relieve abnormal thickening condition of the epidermis layer and reduce the number of skin mast cells, and can be widely used in skin care products for relieving and resisting sensitization. Cell experiments show that the cogongrass rhizome can play a role in resisting inflammation and relieving skin irritation by being independently used, and the anti-inflammatory effect can be improved by being combined with the ophiopogon root extract and the purslane extract with similar effects. The combined extract is applied to gel cosmetic products, and the prepared products have transparent appearance, fresh and cool use feeling and good moisturizing effect.
Description
Technical Field
The invention relates to a plant extract composition and a cosmetic, in particular to a plant extract composition and a cosmetic with anti-allergy and relieving effects, and belongs to the technical field of traditional Chinese medicines and the technical field of cosmetics.
Background
Sensitive skin is a kind of skin which is easy to feel stinging, burning and the like under the stimulation of external physics, chemistry, cold and hot, and the like, and especially is most on the face. It is mainly characterized in that itching and stinging feeling occur after external stimulation, and phenomena such as dryness, desquamation, erythra and the like are easy to occur. According to the cosmetic classification rules and classification catalogues issued by the national drug administration, the "soothing" efficacy is interpreted as being beneficial to improving the state of skin irritation and the like. Raw materials derived from natural plants have a higher specific gravity in the cosmetic field and are increasingly favored by consumers due to the guidance of concepts such as green, mild, sustainable, etc.
The cogongrass rhizome, also called as the root of cymbidium, the root of cogongrass, the root of sweet grass, the sugarcane, etc., is the dry rhizome of cogongrass (Imperata cylindrical Beauv. Var. Major (Nees) C.E. Hubb.) of cogongrass of Gramineae, has sweet and cold taste, has the effects of cooling blood, stopping bleeding, clearing heat, promoting urination, etc. Bai Mao Gen is originally carried in Shen nong Ben Cao Jing (Shen nong's herbal), and is mainly used for treating febrile disease, polydipsia, hematemesis, dyspnea due to lung heat, difficult urination, edema, jaundice and the like. The cogongrass rhizome contains a plurality of chemical components such as polysaccharide, triterpene, flavone, coumarin, phenolic acid and the like, and modern pharmacological researches show that the cogongrass rhizome has wide biological activity, such as a plurality of pharmacological effects such as antioxidation, anti-inflammatory, anti-tumor, antibiosis, hemostasis and immunoregulation.
The application of cogongrass rhizome is mainly used in oral care products, hemostatic products, moisturizing products and the like at present. Chinese patent CN103385848A discloses a method for preparing a toning lotion with moisturizing, skin elasticity enhancing and wrinkle reducing effects, wherein lalang grass rhizome extract is compounded with a plurality of active ingredients. Chinese patent CN105640868A discloses a pearl amino acid moisturizing mask and a preparation method thereof, wherein cogongrass rhizome extract and other active ingredients are synergistic to act, and the moisturizing mask has the functions of relieving tiredness and darkness of skin after being decocted, moisturizing and brightening.
Chinese patent CN107184860A discloses a traditional Chinese medicine composition with the effects of relieving itching, resisting contact eczema and contact dermatitis, which is obtained by decocting 6 traditional Chinese medicine compounds including cogongrass rhizome with water, and can clear heat, cool blood, invigorate spleen, promote diuresis and cope with acute eczema. However, the effect is realized on the basis of the synergistic effect of the whole traditional Chinese medicine compound, and the oral administration mode is adopted. Although the cogongrass rhizome has long history of use as a medicinal and edible traditional Chinese medicine, the application of cogongrass rhizome extract on the skin surface alone is not reported at present, and the effect of relieving the effect and improving the skin irritation state is exerted.
Therefore, the cogongrass rhizome extract with the relieving effect and the skin stimulation improving effect has important significance.
Disclosure of Invention
The invention aims to: the object of the present invention is to provide a plant extract composition which can improve skin irritation and has an antiallergic and soothing effect; another object of the present invention is to provide a cosmetic containing the above plant extract composition; another object of the present invention is to provide a method for preparing the above cosmetic.
The technical scheme is as follows: the plant extract composition with the antiallergic and soothing effects comprises a cogongrass rhizome extract, a dwarf lilyturf tuber extract and a purslane extract. Preferably, in the plant extract composition, the mass ratio of the cogongrass rhizome extract to the dwarf lilyturf tuber extract to the purslane extract is 1:1:1.
As a further improvement of the above scheme, the cogongrass rhizome extract is prepared by the following method: reflux-extracting the dried and pulverized lalang grass rhizome powder with ethanol water solution under stirring, concentrating the filtrate under reduced pressure, and drying.
As a further improvement of the scheme, in the preparation method of the cogongrass rhizome extract, cogongrass rhizome powder is 60-80 meshes, the stirring reflux extraction time is 2-3 hours, the volume of the ethanol aqueous solution of the extract is 10-20 times of the mass of cogongrass rhizome powder, the extraction times are more than or equal to 2 times, and the temperature of reduced pressure concentration is 40-50 ℃.
In another aspect, the present invention provides a soothing anti-allergic cosmetic comprising the plant extract composition described above.
As a further improvement of the above scheme, the cosmetic comprises the following components in percentage by weight:
preferably, the emulsifier is at least one of PEG-40, glyceryl caprylate and lecithin; preferably, the carbomer is carbomer 940, carbomer 941, carbomer 980 or carbomer U20; preferably, the humectant is at least one of glycerin, butylene glycol and ethylene glycol; preferably, the pH regulator is triethanolamine or EDTA-disodium.
Preferably, the cosmetics are cream emulsion type, membrane powder type, gel type, aerosol type or powder cake type cosmetics.
On the other hand, the preparation method of the soothing and antiallergic cosmetic comprises the following steps of: (1) phase A: swelling carbomers with a small amount of water; (2) phase B: dissolving lalang grass rhizome extract with small amount of ethanol, adding emulsifying agent for dissolving, and volatilizing ethanol; (3) phase C: dissolving radix Ophiopogonis extract, herba Portulacae extract, pH regulator, humectant and antiseptic with water; (4) Mixing and dissolving the phase B and the phase C, stirring and dissolving the mixture in the phase A, adjusting the pH value, and filling.
Preferably, in the step (2), the dissolution temperature of the cogongrass rhizome extract in ethanol is 60-70 ℃; preferably, in step (3), the dissolution temperature is 50-60 ℃.
The relieving and anti-sensitization comprises one or more actions of improving skin irritation, reducing skin inflammation, itching and desquamation, relieving abnormal thickening of epidermis layers and reducing the number of mast cells.
The cogongrass rhizome extract is obtained by ethanol extraction and freeze drying. Animal experiments show that the cogongrass rhizome extract as an active ingredient can reduce the skin inflammation desquamation condition, reduce scratching condition, relieve abnormal thickening condition of the epidermis layer and reduce the number of skin mast cells, and can be widely used in skin care products for relieving and resisting sensitization. Cell experiments show that the cogongrass rhizome can play a role in resisting inflammation and relieving skin irritation by being independently used, and the anti-inflammatory effect can be improved by being combined with the ophiopogon root extract and the purslane extract with similar effects. The combined extract is applied to gel cosmetic products, and the prepared products have transparent appearance, fresh and cool use feeling and good moisturizing effect.
The beneficial effects are that: compared with the prior art, the invention has the following remarkable advantages: the ophiopogon root extract has good moisturizing effect, the purslane extract has the effects of resisting oxidization and allergy, and the anti-inflammatory effect can be remarkably improved after the purslane extract is combined with the cogongrass rhizome extract.
Drawings
FIG. 1 is a graph showing the dorsal inflammatory conditions of mice in each group.
FIG. 2 shows the result of hematoxylin-eosin staining of the back skin of mice (200X);
FIG. 3 shows the result of blue staining of toluidine on the back skin of mice (400X);
FIG. 4 shows hyaluronidase inhibitory activity of cogongrass rhizome extract;
FIG. 5 is a graph showing the NO production rate of 100mg/ml extract and the same concentration composition.
Detailed Description
The technical scheme of the invention is further described below with reference to the accompanying drawings.
Embodiment one: preparation of lalang grass rhizome extract
(1) Drying and crushing cogongrass rhizome, and sieving to obtain 60-mesh powder; adding 95% (v/v) ethanol solution with volume of 20 times, mixing, and reflux extracting at 80deg.C under stirring for 2 hr to obtain extractive solution.
(2) Repeating step (1) for three times, mixing the obtained extracts, filtering, collecting filtrate, concentrating the filtrate under reduced pressure at 40deg.C, freeze drying, grinding and pulverizing the dried extract, and sealing and storing.
Embodiment two: preparation of lalang grass rhizome extract
(1) Drying and crushing cogongrass rhizome, and sieving to obtain 80-mesh powder; adding 95% (v/v) ethanol solution with volume of 20 times, mixing, and reflux extracting at 80deg.C under stirring for 2 hr to obtain extractive solution.
(2) Repeating step (1) twice, mixing the obtained extracts, filtering, collecting filtrate, concentrating the filtrate under reduced pressure at 50deg.C, freeze drying, grinding and pulverizing the dried extract, and sealing and storing.
Embodiment III: preparation of lalang grass rhizome extract
(1) Drying and crushing cogongrass rhizome, and sieving to obtain 60-mesh powder; adding 10 times of 95% (v/v) ethanol solution, mixing, and reflux extracting at 70deg.C under stirring for 3 hr to obtain extractive solution.
(2) Repeating step (1) for three times, mixing the obtained extracts, filtering, collecting filtrate, concentrating the filtrate under reduced pressure at 40deg.C, freeze drying, grinding and pulverizing the dried extract, and sealing and storing.
Embodiment four: preparation of lalang grass rhizome extract
(1) Drying and crushing cogongrass rhizome, and sieving to obtain 80-mesh powder; adding 10 times of 95% (v/v) ethanol solution, mixing, and reflux extracting at 80deg.C under stirring for 2 hr to obtain extractive solution.
(2) Repeating step (1) for three times, mixing the obtained extracts, filtering, collecting filtrate, concentrating the filtrate under reduced pressure at 40deg.C, freeze drying, grinding and pulverizing the dried extract, and sealing and storing.
Example five
Based on a mouse skin allergy experiment, the relief efficacy of the cogongrass rhizome extract is verified
(1) Grouping and modeling of animals
15 SPF-grade female ICR mice were housed adaptively for one week. On day 0, long hairs of the skin of the back of the mice were removed using an animal hair remover, and were dehaired using a dehairing paste. Mice were randomly grouped according to body weight into 3 groups, which were a blank control group, a model group, and a lalang grass rhizome extract administration group, each group being 5.
100 μl of 1% (w/v) DNCB solution was applied to the back of the mice in the model group and the mice in the dosing group were sensitized on the hair removal sites from day 1, and the blank group was not treated with any treatment, and sensitized 3 times per day.
From day 8, 100 μl of 0.5% (w/v) DNCB solution was used to apply the excitation to the back dehairing sites of mice in the model group, the intervention group, once every two days.
(2) Preparation and administration method of medicine
Preparing a cogongrass rhizome extract solution:
150mg of the cogongrass rhizome extract powder prepared in the example 1 is precisely weighed, 5mL of physiological saline is added, and the mixture is dissolved by ultrasonic waves to fix the volume.
The administration method comprises the following steps:
from day 10, 100 μl of cogongrass rhizome extract solution with a concentration of 30mg/ml was smeared on the back modeling site of the mice of the administration group, the mice of the model group were smeared with physiological saline, and the blank control group was not treated with any treatment once a day for 14 consecutive days.
(1) Evaluation of the score of skin inflammation and the number of scratches on the back of the mice: the skin damage condition of the back of the mouse is observed, photographing is carried out regularly, and the specific condition is recorded. The back skin of the mice was scored for four conditions (0 none, 1 mild, 2 moderate, 3 severe). Placing the mice in a conventional mouse cage, adapting to the mice for 30min, observing the back-to-back occlusion of the mouth of the mice, scratching the back by the hind paws, and recording the number of times of scratching the stimulation part of the mice within 15 min.
TABLE 1 Effect of lalang grass rhizome extract on Back inflammation Condition and itching in mice
From the data in Table 1 and as shown in FIG. 1, it was found that the back inflammation level of the mice to which the lalang grass rhizome extract was administered was significantly reduced, and the conditions such as crusting, desquamation, and redness and swelling were reduced, as compared with the mice in the model group. According to the data in Table 1, the number of scratches of the mice in the model group and the mice in the cogongrass rhizome extract administration group was increased, but the number of scratches of the mice in the cogongrass rhizome extract administration group was lower than that in the model group, and the increase amplitude was also lower than that of the mice in the model group. The cogongrass rhizome extract has the functions of reducing inflammation, reducing itching and relieving skin sensitivity.
(2) Mouse back skin epidermis layer thickness measurement
After the last administration, the mice were sacrificed by cervical spine removal, the skin at the back of the mice was peeled off and fixed with 4% (w/v) paraformaldehyde. And (3) carrying out dewatering wax leaching on the fixed skin sample, embedding the skin sample in an embedding machine, and trimming wax blocks. And (3) placing the trimmed wax block into a freezing table at the temperature of minus 20 ℃ for cooling, and then placing the cooled wax block into a paraffin slicer to prepare slices with the thickness of 4 mu m. Paraffin sections were dewaxed to water, stained with hematoxylin, eosin stained, de-watered, and observed under a microscope at 200x magnification, three field-of-view photographic recordings were selected for each section, and the skin layer thickness was determined using imagej software.
TABLE 2 Effect of lalang grass rhizome extract on abnormal proliferation of the epidermal layers of the back skin of mice
From the data shown in FIG. 2 and Table 2, the skin structure of mice in the blank group was regular, the cell morphology was normal, and the tissue structure was normal. The thickness of the epidermis layer of the mice in the model group is obviously increased, a certain degree of hyperkeratosis is caused, and acanthosis exists. Compared with the mice in the model group, the excessive keratinization phenomenon of the epidermis of the mice in the group of the cogongrass rhizome extract administration group is reduced, the thickness of the epidermis layer is obviously lower, and the difference is obvious. The cogongrass rhizome extract has the good effects of improving the skin irritation condition and slowing down the abnormal increase of the epidermal layer thickness.
(3) Mouse back skin mast cell count
Dewaxing the prepared paraffin sections to water, carrying out toluidine blue dyeing, washing with tap water, drying, sealing the sections in a transparent way, magnifying the sections by 400 times under a microscope, selecting three visual fields for each section for observation, and counting the number of mast cells.
TABLE 3 Effect of lalang grass rhizome extract on mice Back skin mast cell infiltration
From the data shown in fig. 3 and table 3, the number of mast cells on the back skin of the mice in the model group was significantly increased compared to that of the mice in the blank group, and the number of mast cells on the back skin of the mice in the lalang grass rhizome extract administration group was significantly different compared to that of the mice in the model group. The mast cells in the skin can generate quick immune response to stimulus factors such as external allergens, and the mast cells can release substances such as cytokines when stimulated, so that the reactions such as inflammation, itching and the like are induced. The cogongrass rhizome extract can reduce the number of mast cells, stabilize the state of the mast cells, relieve the external stimulus to the skin and relieve the skin sensitivity.
Example six
Based on in vitro hyaluronidase activity inhibition test, the anti-allergy relieving effect of cogongrass rhizome extract is verified
0.1ml of 0.25mmol/L CaCl was taken 2 Incubating the solution with 0.5ml hyaluronidase solution at 37deg.C for 20min; adding 0.5ml of sample solution, and keeping the temperature at 37 ℃ for 20min; adding 0.5ml sodium hyaluronate solution, maintaining at 37deg.C for 30min, and standing at normal temperature for 5min; adding 0.1ml of 0.4mol/L NaOH solution and 0.5ml of acetylacetone solution, placing in a boiling water bath, heating for 15min, and immediately cooling with ice water for 5min; 1.0ml of the Escherichia reagent was added and diluted with 3.0ml of absolute ethanol, followed by standing for 20 minutes to develop a color, and the absorbance was measured by a spectrophotometer. The positive control used dipotassium glycyrrhizinate.
Hyaluronidase is a specific hydrolase of hyaluronic acid, and researches show that the hyaluronidase is closely related to inflammation and anaphylactic reaction of organisms, so that a hyaluronidase activity inhibition test is an important biochemical evaluation method of anti-allergy and relieving activities of substances. The experimental results are shown in FIG. 4. Based on the results of the hyaluronidase activity inhibition test, the inhibition activities of the cogongrass rhizome extract and the positive control dipotassium glycyrrhizinate on the hyaluronidase are enhanced along with the increase of the concentration, and when the concentration of the cogongrass rhizome extract reaches 10mg/ml, the inhibition rate of the cogongrass rhizome extract on the hyaluronidase reaches 84.17 +/-10.32%, which indicates that the cogongrass rhizome extract has good antiallergic and soothing activity.
Example seven
Based on RAW264.7 cell inflammation model, anti-inflammatory efficacy of the composition is verified
Inoculating cells in logarithmic growth phase into 96-well plate with density of 5×10 5 mu.L per well per ml. After cell attachment, RAW264.7 cells were stimulated by the addition of 100ng/ml LPS and 100mg/ml extract, and no extract was added to the model group with 100ng/ml LPS alone. The concentration of the composition is 100mg/ml, and the proportion is cogongrass rhizome extract: radix Ophiopogonis extract: purslane extract 1:1:1. After 24 hours, the cell supernatants were collected and assayed for NO content using gris reagent. The experimental results are shown in fig. 5, and the production rates of inflammatory mediators NO in the model group, the cogongrass rhizome extract group, the dwarf lilyturf tuber extract group, the purslane extract group and the composition group are respectively 99.85+/-0.66%, 78.93+/-1.39%, 75.47 +/-3.00%, 75.90+/-1.09% and 54.40+/-0.25%. The combined extract with the same concentration can obviously improve the anti-inflammatory capability of inhibiting the generation of NO, and is superior to the single application of the extract with the same concentration.
Example eight
The weight percentages are as follows: carbomer 941 type 0.5%, composition 0.5%, EDTA-disodium 0.04%, ethylene glycol 0.4%, butylene glycol 0.4%, glycerin 5%, PEG-40% 3%, p-hydroxyacetophenone 0.4%, the balance being water. Prepared to a 100ml gauge.
According to the above formula, the preparation is carried out according to the following steps:
(1) phase A: swelling carbomer 940 with a small amount of water;
(2) and B phase: dissolving lalang grass rhizome extract with small amount of ethanol at 60-70deg.C, adding PEG-40 for dissolving, and volatilizing ethanol;
(3) and C phase: dissolving radix Ophiopogonis extract, herba Portulacae extract, EDTA-disodium, butanediol, ethylene glycol, glycerol, and p-hydroxyacetophenone with water at 50-60deg.C;
(4) mixing and dissolving the phase B and the phase C, stirring and dissolving the mixture in the phase A, adjusting the pH value, and filling.
Comparative example 1
The formulation used was carbomer 940, otherwise the same as in example 1.
Comparative example 2
Carbomer 980 was used in the formulation, otherwise as in example 1.
Comparative example 3
Carbomer U20 was used in the formulation, otherwise as in example 1.
Comparative example 4
The formulation used was 0.3% carbomer 941, otherwise as in example 1.
Comparative example 5
The formulation used was 0.7% carbomer 941, otherwise as in example 1.
Comparative example 6
The formulation used was 0.9% carbomer 941, otherwise as in example 1.
Comparative example 7
The formulation used was 1.1% carbomer 941, otherwise as in example 1.
Comparative example 8
The composition content in the formulation was 0.3%, otherwise the same as in example 1.
Comparative example 9
The composition content in the formulation was 0.7%, otherwise the same as in example 1.
Comparative example 10
The composition content in the formulation was 0.9%, otherwise the same as in example 1.
Example nine
15 healthy volunteers aged between 20 and 40 years were selected, and after the face was cleaned, example eight and comparative examples 1 to 10 were respectively smeared on both sides of the cheek, and the effect of use was observed and felt.
Scoring was performed according to the following table.
Table 4 shows sensory evaluation criteria of the products
The evaluation experience of volunteers is shown in the following table:
table 5 shows the results of volunteer evaluation
Group of | Evaluation of total score |
Example eight | 80.71 |
Comparative example 1 | 70.64 |
Comparative example 2 | 67.64 |
Comparative example 3 | 75.71 |
Comparative example 4 | 81.00 |
Comparative example 5 | 77.00 |
Comparative example 6 | 74.86 |
Comparative example 7 | 73.14 |
Comparative example 8 | 79.50 |
Comparative example 9 | 82.00 |
Comparative example 10 | 82.21 |
As is clear from table 5, the evaluation score of example eight was excellent, and the appearance, the feel after application, and the feel after application were all good.
Claims (10)
1. A plant extract composition with anti-allergy and soothing effects, which is characterized by comprising lalang grass rhizome extract, dwarf lilyturf tuber extract and purslane extract.
2. The plant extract composition with antiallergic soothing effect of claim 1, wherein the cogongrass rhizome extract is prepared by the following method: reflux-extracting the dried and pulverized lalang grass rhizome powder with ethanol water solution under stirring, concentrating the filtrate under reduced pressure, and drying.
3. The plant extract composition with antiallergic and soothing effects according to claim 2, wherein in the preparation method of the cogongrass rhizome extract, cogongrass rhizome powder is 60-80 meshes, the stirring reflux extraction time is 2-3 hours, the volume of the ethanol aqueous solution of the extract is 10-20 times of the mass of cogongrass rhizome powder, the extraction times are more than or equal to 2 times, and the temperature of reduced pressure concentration is 40-50 ℃.
4. A soothing anti-sensitization cosmetic, characterized in that it comprises the plant extract composition according to any one of claims 1 to 3.
6. the soothing and anti-sensitization cosmetic according to claim 5, wherein the emulsifier is at least one of PEG-40, caprylic capric glyceride and lecithin; the carbomer is carbomer 940 type, carbomer 941 type, carbomer 980 type or carbomer U20 type.
7. The soothing and anti-sensitization cosmetic according to claim 5, wherein the humectant is at least one of glycerin, butylene glycol and ethylene glycol; the PH regulator is triethanolamine or EDTA-disodium.
8. The soothing and anti-sensitization cosmetic according to claim 7, wherein the cosmetic is a cream emulsion, a film powder, a gel, an aerosol or a powder cake cosmetic.
9. A method for preparing a soothing anti-allergic cosmetic according to any one of claims 5 to 8, characterized in that it comprises the following steps: (1) phase A: swelling carbomers with a small amount of water; (2) phase B: dissolving lalang grass rhizome extract with small amount of ethanol, adding emulsifying agent for dissolving, and volatilizing ethanol; (3) phase C: dissolving radix Ophiopogonis extract, herba Portulacae extract, pH regulator, humectant and antiseptic with water; (4) Mixing and dissolving the phase B and the phase C, stirring and dissolving the mixture in the phase A, adjusting the pH value, and filling.
10. The preparation method according to claim 9, wherein in the step (2), the dissolution temperature of the cogongrass rhizome extract in ethanol is 60-70 ℃; in the step (3), the dissolution temperature is 50-60 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310053921.3A CN116035991A (en) | 2023-02-03 | 2023-02-03 | Plant extract composition with antiallergic and soothing effects and cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310053921.3A CN116035991A (en) | 2023-02-03 | 2023-02-03 | Plant extract composition with antiallergic and soothing effects and cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116035991A true CN116035991A (en) | 2023-05-02 |
Family
ID=86129398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310053921.3A Pending CN116035991A (en) | 2023-02-03 | 2023-02-03 | Plant extract composition with antiallergic and soothing effects and cosmetic |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116035991A (en) |
-
2023
- 2023-02-03 CN CN202310053921.3A patent/CN116035991A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108670943A (en) | A kind of moisturizing, whitening, light spot composition of plant extracts | |
CN110882207B (en) | Preparation process and method of essence for skin repair | |
CN115120547B (en) | Non-irritating hair repair composition and anti-hair-loss shampoo | |
CN113057930A (en) | Mite-removing face cream containing rosemary and preparation method thereof | |
CN117530904A (en) | Plant composition with anti-hair loss effect and shampoo | |
KR100712249B1 (en) | Oily to acne skin cosmetics composite containing oriental herb extract and manufacturing method thereof | |
KR101443182B1 (en) | Oriental medicine extrct for preventing hair loss and promoting hair growth, manufacturing method thereof and cosmetic composition for growing hair using the same | |
CN105998617B (en) | External traditional Chinese medicine extract with effect of relieving senile skin itch and preparation method and application thereof | |
CN107157859A (en) | A kind of face mask of traditional Chinese medicine with nti-freckle, whitening and nourishing effect and preparation method thereof | |
CN109303724A (en) | A kind of novel maintenance stoste composition of releiving containing folium artemisiae argyi | |
CN104814916A (en) | Moisturizing essence and preparing method thereof | |
CN114469801B (en) | Agilawood shampoo for regulating scalp microecological balance and preparation method thereof | |
CN105232606B (en) | A topical pharmaceutical composition for treating acne, and its preparation method | |
CN115054566B (en) | Scalp aging resisting composition and preparation method thereof | |
CN111407707A (en) | Plant-derived skin health-care lotion and preparation method thereof | |
CN108078827B (en) | Alopecia-stopping and hair-growing shampoo and preparation method thereof | |
CN116035991A (en) | Plant extract composition with antiallergic and soothing effects and cosmetic | |
CN113768803A (en) | Composition of spray for preventing alopecia and removing dandruff and preparation method | |
CN113499271A (en) | Anti-allergy compound and preparation method and application thereof | |
CN113749971A (en) | Skin care formula with anti-aging, whitening, moisturizing and skin care functions and preparation method thereof | |
CN114081855A (en) | Intelligent-care and beauty-care colorful facial mask and preparation method thereof | |
CN113069389A (en) | Liquorice anti-allergy repair essence and preparation method thereof | |
CN112516043A (en) | A Chinese medicinal shampoo with effects of blackening hair, promoting hair growth, relieving itching and removing dandruff | |
KR101188216B1 (en) | Natural complex extract Composition for preventing falling out of the hair and promoting growth of the hair containing black soybean paste's active principle | |
CN109674890B (en) | Composition and skin care product for preventing and/or treating skin red blood streak and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |